Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2022 Filed Jan 4, 2022 21:19 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001209191-22-000730 · doc4.xml · derivative · entry 5 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,905 Underlying: Common Stock · 1,428 shares Expires 2030-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning May 28, 2020 until the option is fully vested on April 28, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:19 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-22-000730 · doc4.xml · derivative · entry 4 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,466 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:19 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 1,828 | $28.96 | $52,938.88 |
DisclosureSEC source: 0001209191-22-000730 · doc4.xml · nonDerivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:19 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 1,428 | $9.57 | $13,665.96 |
DisclosureSEC source: 0001209191-22-000730 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:19 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-22-000730 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:47 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-069260 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,266 Underlying: Common Stock · 1,200 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:47 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 1,200 | $29.04 | $34,848.00 |
DisclosureSEC source: 0001209191-21-069260 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:47 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 1,200 | $1.86 | $2,232.00 |
DisclosureSEC source: 0001209191-21-069260 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:43 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-067685 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,866 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:43 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 400 | $29.13 | $11,652.00 |
DisclosureSEC source: 0001209191-21-067685 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:43 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-21-067685 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-064270 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,466 Underlying: Common Stock · 1,200 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 1,200 | $32.38 | $38,856.00 |
DisclosureSEC source: 0001209191-21-064270 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:15 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 1,200 | $1.86 | $2,232.00 |
DisclosureSEC source: 0001209191-21-064270 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:28 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-062466 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,266 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:28 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 400 | $33.24 | $13,296.00 |
DisclosureSEC source: 0001209191-21-062466 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:28 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-21-062466 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:23 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-061973 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,666 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:23 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 400 | $35.00 | $14,000.00 |
DisclosureSEC source: 0001209191-21-061973 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:23 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-21-061973 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:25 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 800 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-061974 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,666 Underlying: Common Stock · 800 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:25 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 800 | $35.25 | $28,200.00 |
DisclosureSEC source: 0001209191-21-061974 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 23:25 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 800 | $1.86 | $1,488.00 |
DisclosureSEC source: 0001209191-21-061974 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:43 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-060286 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,466 Underlying: Common Stock · 1,200 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:43 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 1,200 | $27.36 | $32,832.00 |
DisclosureSEC source: 0001209191-21-060286 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:43 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 1,200 | $1.86 | $2,232.00 |
DisclosureSEC source: 0001209191-21-060286 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:16 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-059064 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,066 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:16 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 400 | $29.92 | $11,968.00 |
DisclosureSEC source: 0001209191-21-059064 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:16 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-21-059064 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:15 UTC |
Silva Paul MDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $31.24 | $0.00 |
DisclosureSEC source: 0001209191-21-059061 · doc4.xml · derivative · entry 1 Silva Paul M · CIK 0001446372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-09-30 F1 · derivative.exercise_date: The stock option vests as to 1/36 of the total shares monthly beginning November 1, 2021 until the option is fully vested on October 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:16 UTC |
Reinsdorf Judith ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $31.24 | $0.00 |
DisclosureSEC source: 0001209191-21-059062 · doc4.xml · derivative · entry 1 Reinsdorf Judith A · CIK 0001305361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-09-30 F1 · derivative.exercise_date: The stock option vests as to 1/36 of the total shares monthly beginning November 1, 2021 until the option is fully vested on October 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:07 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-055663 · doc4.xml · derivative · entry 5 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,666 Underlying: Common Stock · 2,000 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:07 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 800 | $36.76 | $29,408.00 |
DisclosureSEC source: 0001209191-21-055663 · doc4.xml · nonDerivative · entry 4 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:07 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 500 | $35.77 | $17,884.20 |
DisclosureSEC source: 0001209191-21-055663 · doc4.xml · nonDerivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,086 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $35.64 and the highest price at which shares were sold was $35.90. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:07 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 700 | $35.10 | $24,567.97 |
DisclosureSEC source: 0001209191-21-055663 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,586 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $34.58 and the highest price at which shares were sold was $35.53. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:07 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 2,000 | $1.86 | $3,720.00 |
DisclosureSEC source: 0001209191-21-055663 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,200 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-055174 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,666 Underlying: Common Stock · 3,200 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Ring ChristineGeneral Counsel
|
SaleCommon Stock | 3,200 | $35.25 | $112,800.00 |
DisclosureSEC source: 0001209191-21-055174 · doc4.xml · nonDerivative · entry 2 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · balance_after: Includes 481 shares of Common Stock acquired by the Reporting Person on August 13, 2021 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionCommon Stock | 3,200 | $1.86 | $5,952.00 |
DisclosureSEC source: 0001209191-21-055174 · doc4.xml · nonDerivative · entry 1 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · balance_after: Includes 481 shares of Common Stock acquired by the Reporting Person on August 13, 2021 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,600 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-055171 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,466 Underlying: Common Stock · 1,600 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 1,600 | $35.00 | $56,000.00 |
DisclosureSEC source: 0001209191-21-055171 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 21:08 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 1,600 | $7.26 | $11,616.00 |
DisclosureSEC source: 0001209191-21-055171 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:22 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001209191-21-054434 · doc4.xml · derivative · entry 3 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,066 Underlying: Common Stock · 400 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option vests as to 1/48 of the total shares monthly beginning February 18, 2020 until the option is fully vested on January 18, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:22 UTC |
Hansen GwennChief Scientific Officer
|
SaleCommon Stock | 400 | $32.34 | $12,936.00 |
DisclosureSEC source: 0001209191-21-054434 · doc4.xml · nonDerivative · entry 2 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · balance_after: Includes 393 shares of Common Stock acquired by the Reporting Person on August 13, 2021 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:22 UTC |
Hansen GwennChief Scientific Officer
|
Exercise / conversionCommon Stock | 400 | $7.26 | $2,904.00 |
DisclosureSEC source: 0001209191-21-054434 · doc4.xml · nonDerivative · entry 1 Hansen Gwenn · CIK 0001817160 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · balance_after: Includes 393 shares of Common Stock acquired by the Reporting Person on August 13, 2021 pursuant to the Issuer's employee stock purchase plan. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 18:20 UTC |
Beaurang PierreChief Business Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-050976 · doc4.xml · derivative · entry 5 Beaurang Pierre · CIK 0001817226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,562 Underlying: Common Stock · 7,500 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 18:20 UTC |
Beaurang PierreChief Business Officer
|
SaleCommon Stock | 1,880 | $30.21 | $56,797.24 |
DisclosureSEC source: 0001209191-21-050976 · doc4.xml · nonDerivative · entry 3 Beaurang Pierre · CIK 0001817226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,330 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $30.07 and the highest price at which shares were sold was $30.34. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 18:20 UTC |
Beaurang PierreChief Business Officer
|
SaleCommon Stock | 5,620 | $29.74 | $167,128.68 |
DisclosureSEC source: 0001209191-21-050976 · doc4.xml · nonDerivative · entry 2 Beaurang Pierre · CIK 0001817226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,210 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $29.07 and the highest price at which shares were sold was $30.06. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 18:20 UTC |
Beaurang PierreChief Business Officer
|
Exercise / conversionCommon Stock | 7,500 | $1.11 | $8,325.00 |
DisclosureSEC source: 0001209191-21-050976 · doc4.xml · nonDerivative · entry 1 Beaurang Pierre · CIK 0001817226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC |
Ring ChristineGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001209191-21-050977 · doc4.xml · derivative · entry 3 Ring Christine · CIK 0001817199 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,866 Underlying: Common Stock · 1,200 shares Expires 2029-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · derivative.exercise_date: The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.